Takeshi Goromaru

482 total citations
34 papers, 399 citations indexed

About

Takeshi Goromaru is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Takeshi Goromaru has authored 34 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Pharmacology. Recurrent topics in Takeshi Goromaru's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Takeshi Goromaru is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). Takeshi Goromaru collaborates with scholars based in Japan, France and United Kingdom. Takeshi Goromaru's co-authors include Kenji Hashimoto, Toshiaki Sendo, Ryozo Oishi, Yoshinori Itoh, Takahisa Yano, Toshio Hirakawa, Hitoo Nakano, Naoko Sakai, Makoto Anraku and Hiroyuki Tsutsumi and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Carbohydrate Polymers and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Takeshi Goromaru

34 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Goromaru Japan 13 132 81 51 48 43 34 399
Heon‐Woo Lee South Korea 15 279 2.1× 24 0.3× 67 1.3× 26 0.5× 79 1.8× 31 595
Amirhosein Sahebkar Iran 14 248 1.9× 23 0.3× 73 1.4× 82 1.7× 78 1.8× 26 628
Jing He China 13 159 1.2× 16 0.2× 42 0.8× 39 0.8× 41 1.0× 47 568
Yuyang Zhang China 16 182 1.4× 30 0.4× 39 0.8× 90 1.9× 48 1.1× 50 701
Hui Bi China 10 125 0.9× 35 0.4× 16 0.3× 30 0.6× 38 0.9× 33 395
José Rubén García-Sánchez Mexico 15 228 1.7× 24 0.3× 37 0.7× 66 1.4× 19 0.4× 45 584
Ali Bidmeshki Pour Iran 8 208 1.6× 23 0.3× 76 1.5× 25 0.5× 31 0.7× 14 757
Hongyan Zhang China 12 135 1.0× 29 0.4× 18 0.4× 23 0.5× 38 0.9× 34 387
Yong Han China 15 369 2.8× 28 0.3× 45 0.9× 39 0.8× 47 1.1× 53 683

Countries citing papers authored by Takeshi Goromaru

Since Specialization
Citations

This map shows the geographic impact of Takeshi Goromaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Goromaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Goromaru more than expected).

Fields of papers citing papers by Takeshi Goromaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Goromaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Goromaru. The network helps show where Takeshi Goromaru may publish in the future.

Co-authorship network of co-authors of Takeshi Goromaru

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Goromaru. A scholar is included among the top collaborators of Takeshi Goromaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Goromaru. Takeshi Goromaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hirose, Masakazu, Yukihisa Matsuda, Keita Ogawa, et al.. (2020). Quantitative Evaluation of Medication Management Ability of Pharmacy Students Utilizing Pharmaceutical Electronic Medication History System. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 46(4). 183–195. 1 indexed citations
3.
Goromaru, Takeshi, et al.. (2008). Antimicrobial Susceptibility of Antibiotic-Resistant Lactic Acid Bacteria and Clostridium Butyricum Preparations to Fluoroquinolones. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 34(1). 59–63. 1 indexed citations
4.
Sendo, Toshiaki, Yoshinori Itoh, Takeshi Goromaru, et al.. (2004). Role of substance P in hypersensitivity reactions induced by paclitaxel, an anticancer agent. Peptides. 25(7). 1205–1208. 9 indexed citations
5.
Itoh, Yoshinori, Toshiaki Sendo, Toshio Hirakawa, et al.. (2004). Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats. Neuropharmacology. 46(6). 888–894. 13 indexed citations
6.
Itoh, Yoshinori, Toshiaki Sendo, Toshio Hirakawa, et al.. (2004). Similarity and difference in the acute lung injury induced by a radiographic contrast medium and an anticancer agent paclitaxel in rats. Toxicology Letters. 152(1). 27–34. 3 indexed citations
7.
Itoh, Yoshinori, Toshiaki Sendo, Toshio Hirakawa, et al.. (2003). Role of Sensory Nerve Peptides Rather than Mast Cell Histamine in Paclitaxel Hypersensitivity. American Journal of Respiratory and Critical Care Medicine. 169(1). 113–119. 32 indexed citations
8.
Sendo, Toshiaki, Yoshinori Itoh, Takeshi Goromaru, et al.. (2003). Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells. Cellular Signalling. 15(8). 773–781. 36 indexed citations
9.
Sendo, Toshiaki, et al.. (2002). Carbazochrome attenuates pulmonary dysfunction induced by a radiographic contrast medium in rats. European Journal of Pharmacology. 450(2). 203–208. 16 indexed citations
10.
11.
Goromaru, Takeshi, et al.. (1994). Isotopic Fractionation of Isopropylantipyrine and Its Deuterated Analogues by Capillary Gas Chromatography.. Biological and Pharmaceutical Bulletin. 17(12). 1635–1639. 5 indexed citations
12.
Hashimoto, Kenji & Takeshi Goromaru. (1992). 4-bromo-6-nitroquipazine: A new ligand for studying 5-hydroxytryptamine uptake sites in vivo. Neuropharmacology. 31(9). 869–874. 7 indexed citations
13.
Matsuki, Yu, et al.. (1992). Effects of Ascorbic Acid on the Metabolic Fate and the Free Radical Formation of Ipronlazid. YAKUGAKU ZASSHI. 112(12). 926–933. 3 indexed citations
14.
Matsuki, Yu, et al.. (1991). Effects of glucose and ascorbic acid on absorption and first pass metabolism of isoniazid in rats.. Chemical and Pharmaceutical Bulletin. 39(2). 445–448. 5 indexed citations
15.
Hashimoto, Kenji & Takeshi Goromaru. (1991). High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: Inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors. Neuropharmacology. 30(2). 113–117. 22 indexed citations
16.
17.
Hashimoto, Kenji & Takeshi Goromaru. (1990). Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine. Neuropharmacology. 29(7). 633–639. 13 indexed citations
18.
Itoh, Ryozo, Koichi ISHIZAKA, & Takeshi Goromaru. (1990). Three-phase voltage-source convertor with controlled DC current for the minimisation of filter capacitance. IEE Proceedings B Electric Power Applications. 137(5). 327–327. 6 indexed citations
19.
Goromaru, Takeshi, et al.. (1986). [Urinary excretion of fentanyl and its metabolites at high-dose infusion].. PubMed. 35(1). 35–9. 6 indexed citations
20.
Goromaru, Takeshi, et al.. (1982). Identification of fentanyl metabolites in rat urine by gas chromatography-mass spectrometry with stable-isotope tracers.. Drug Metabolism and Disposition. 10(5). 542–546. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heon‐Woo Lee Breakdown of academic impact, for papers by Amirhosein Sahebkar Breakdown of academic impact, for papers by Jing He Breakdown of academic impact, for papers by Yuyang Zhang Breakdown of academic impact, for papers by Hui Bi Breakdown of academic impact, for papers by José Rubén García-Sánchez Breakdown of academic impact, for papers by Ali Bidmeshki Pour Breakdown of academic impact, for papers by Hongyan Zhang Breakdown of academic impact, for papers by Yong Han
Rankless by CCL
2026